Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron R Hansen

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
Clinical Genitourinary Cancer|January 14, 2020
Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell CarcinomaJ Connor Wells, Jeffrey Graham, Benoit Beuselinck, et al.
Cancer Reports (Hoboken, N.J.)|December 14, 2022
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinomaAmbica Parmar, Sunita Ghosh, Arjun Sahgal, et al.
Investigational New Drugs|May 20, 2024
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trialAndrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Plos One|December 1, 2021
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory studyEsmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, et al.
JCO Oncology Practice|June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance RecommendationsCiara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
JNCI Cancer Spectrum|May 31, 2021
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With ImmunotherapyDaniel V Araujo, Ao Wang, Dax Torti, et al.
Investigational New Drugs|February 7, 2024
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trialAndrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Advances in Radiation Oncology|July 11, 2022
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information SystemEric K Nguyen, Aly Khan A Lalani, Sunita Ghosh, et al.
Oral Oncology|January 28, 2021
Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinomaAvinash Pilar, Eugene Yu, Jie Su, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Clinical Genitourinary Cancer|January 14, 2020
Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell CarcinomaJ Connor Wells, Jeffrey Graham, Benoit Beuselinck, et al.
Cancer Reports (Hoboken, N.J.)|December 14, 2022
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinomaAmbica Parmar, Sunita Ghosh, Arjun Sahgal, et al.
Investigational New Drugs|May 20, 2024
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trialAndrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Plos One|December 1, 2021
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory studyEsmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, et al.
JCO Oncology Practice|June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance RecommendationsCiara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
JNCI Cancer Spectrum|May 31, 2021
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With ImmunotherapyDaniel V Araujo, Ao Wang, Dax Torti, et al.
Investigational New Drugs|February 7, 2024
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trialAndrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Advances in Radiation Oncology|July 11, 2022
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information SystemEric K Nguyen, Aly Khan A Lalani, Sunita Ghosh, et al.
Oral Oncology|January 28, 2021
Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinomaAvinash Pilar, Eugene Yu, Jie Su, et al.
Pageof 18